Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125875221 | 12587522 | 1 | I | 20160718 | 20160725 | 20160725 | EXP | US-009507513-1607USA008080 | MERCK | 0.00 | M | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125875221 | 12587522 | 1 | PS | ZETIA | EZETIMIBE | 1 | Oral | 10 MG, UNK | U | 21445 | 10 | MG | TABLET | ||||||
| 125875221 | 12587522 | 2 | SS | ZOCOR | SIMVASTATIN | 1 | Oral | 20 MG, UNK | U | 0 | 20 | MG | TABLET | ||||||
| 125875221 | 12587522 | 3 | SS | DOXORUBICIN | DOXORUBICIN | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 4 | SS | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
| 125875221 | 12587522 | 5 | SS | LINZESS | LINACLOTIDE | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 6 | SS | OXYCODONE | OXYCODONE | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 7 | SS | MELATONIN | MELATONIN | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 8 | SS | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 9 | SS | COLACE | DOCUSATE SODIUM | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 10 | SS | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 11 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 12 | SS | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 13 | SS | TOPOTECAN | TOPOTECANTOPOTECAN HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 14 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 15 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 16 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | UNK | U | 0 | ||||||||||
| 125875221 | 12587522 | 17 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125875221 | 12587522 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125875221 | 12587522 | Abdominal pain | |
| 125875221 | 12587522 | Anxiety | |
| 125875221 | 12587522 | Depression | |
| 125875221 | 12587522 | Dry mouth | |
| 125875221 | 12587522 | Muscle atrophy | |
| 125875221 | 12587522 | Nasopharyngeal cancer | |
| 125875221 | 12587522 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |